Skip to main content

Table 2 Predicted 10-year CVD risk in Haiti CVD Cohort

From: Comparing six cardiovascular risk prediction models in Haiti: implications for identifying high-risk individuals for primary prevention

 

Haitian cohort (N = 1345)

CVD Risk Estimation Method

N (%)

Pooled Cohort Equations (PCE)

 Median (25th to 75th percentile)

6.1 [2.7, 12.2]

 Low risk (< 5%)

588 (43.7)

 Intermediate (5 to < 7.5%)

200 (14.9)

 High (≥ 7.5%)

557 (41.4)

 Statin eligibilitya

563 (41.9)

adjusted Pooled Cohort Equations (adjusted PCE)

 Median (25th to 75th percentile)

3.6 [1.7, 8.2]

 Low risk (< 5%)

813 (60.4)

 Intermediate (5 to < 7.5%)

164 (12.2)

 High (≥ 7.5%)

368 (27.4)

 Statin eligibilitya

408 (30.3)

Framingham-Lipids

 Median (25th to 75th percentile)

8.2 [4.2, 16.4]

 Low (< 10%)

776 (57.7)

 Intermediate (10 to < 20%)

327 (24.3)

 High (≥ 20%)

242 (18.0)

 Statin eligibilitya

344 (25.6)

Framingham-BMI

 Median (25th to 75th percentile)

9.6 [4.9, 18.0]

 Low (< 10%)

689 (51.2)

 Intermediate (10 to < 20%)

360 (26.8)

 High (≥ 20%)

296 (22.0)

 Statin eligibilitya

362 (27.0)

WHO-Lipids

 Median (25th to 75th percentile)

4.0 [2.0, 8.0]

 Low risk (< 5%)

685 (50.9)

 Intermediate-high-risk (5 to < 20%)

627 (46.6)

 High (≥ 20%)

33 (2.5)

 Statin eligibilitya

33 (2.5)

WHO-BMI

 Median (25th to 75th percentile)

4.0 [2.0, 8.0]

 Low risk (< 5%)

678 (50.4)

 Intermediate-high-risk (5 to < 20%)

643 (47.8)

 High (≥ 20%)

24 (1.8)

 Statin eligibilitya

24 (1.8)

  1. Legend: a statin eligibility criteria by each model is detailed in the Supplement. 95% CI calculated using one sample proportions test.